1,970
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular

Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in Australia

, ORCID Icon & ORCID Icon
Pages 123-130 | Received 21 Oct 2020, Accepted 15 Dec 2020, Published online: 19 Jan 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.